
Use of anxiety-screening questionnaires in patients needing intravitreal anti-VEGF injections may help to identify individuals at risk for elevated pain during the procedure, according to research presented at ARVO 2020.


Use of anxiety-screening questionnaires in patients needing intravitreal anti-VEGF injections may help to identify individuals at risk for elevated pain during the procedure, according to research presented at ARVO 2020.

A large case-control study found that among adults aged 55 years and older, the use of metformin significantly decreased the risk of being newly diagnosed with age-related macular degeneration within 2 years.





